Cargando…
EPH100 Evaluation of COVID-19 Vaccines in Primary Prevention Against Infections and Reduction in Severity of Illness Following the Outbreak of Sars-Cov-2 Omicron Variant in Shanghai
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256563/ http://dx.doi.org/10.1016/j.jval.2023.03.982 |
| _version_ | 1785057132400345088 |
|---|---|
| author | Yang, D. Weng, H. Song, Y. Li, J. Lu, X. Yang, W. Chen, Z. Xuan, J. Bai, C. Wang, Y. |
| author_facet | Yang, D. Weng, H. Song, Y. Li, J. Lu, X. Yang, W. Chen, Z. Xuan, J. Bai, C. Wang, Y. |
| author_sort | Yang, D. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10256563 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102565632023-06-12 EPH100 Evaluation of COVID-19 Vaccines in Primary Prevention Against Infections and Reduction in Severity of Illness Following the Outbreak of Sars-Cov-2 Omicron Variant in Shanghai Yang, D. Weng, H. Song, Y. Li, J. Lu, X. Yang, W. Chen, Z. Xuan, J. Bai, C. Wang, Y. Value Health Article Elsevier 2023-06 2023-06-10 /pmc/articles/PMC10256563/ http://dx.doi.org/10.1016/j.jval.2023.03.982 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Yang, D. Weng, H. Song, Y. Li, J. Lu, X. Yang, W. Chen, Z. Xuan, J. Bai, C. Wang, Y. EPH100 Evaluation of COVID-19 Vaccines in Primary Prevention Against Infections and Reduction in Severity of Illness Following the Outbreak of Sars-Cov-2 Omicron Variant in Shanghai |
| title | EPH100 Evaluation of COVID-19 Vaccines in Primary Prevention Against Infections and Reduction in Severity of Illness Following the Outbreak of Sars-Cov-2 Omicron Variant in Shanghai |
| title_full | EPH100 Evaluation of COVID-19 Vaccines in Primary Prevention Against Infections and Reduction in Severity of Illness Following the Outbreak of Sars-Cov-2 Omicron Variant in Shanghai |
| title_fullStr | EPH100 Evaluation of COVID-19 Vaccines in Primary Prevention Against Infections and Reduction in Severity of Illness Following the Outbreak of Sars-Cov-2 Omicron Variant in Shanghai |
| title_full_unstemmed | EPH100 Evaluation of COVID-19 Vaccines in Primary Prevention Against Infections and Reduction in Severity of Illness Following the Outbreak of Sars-Cov-2 Omicron Variant in Shanghai |
| title_short | EPH100 Evaluation of COVID-19 Vaccines in Primary Prevention Against Infections and Reduction in Severity of Illness Following the Outbreak of Sars-Cov-2 Omicron Variant in Shanghai |
| title_sort | eph100 evaluation of covid-19 vaccines in primary prevention against infections and reduction in severity of illness following the outbreak of sars-cov-2 omicron variant in shanghai |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256563/ http://dx.doi.org/10.1016/j.jval.2023.03.982 |
| work_keys_str_mv | AT yangd eph100evaluationofcovid19vaccinesinprimarypreventionagainstinfectionsandreductioninseverityofillnessfollowingtheoutbreakofsarscov2omicronvariantinshanghai AT wengh eph100evaluationofcovid19vaccinesinprimarypreventionagainstinfectionsandreductioninseverityofillnessfollowingtheoutbreakofsarscov2omicronvariantinshanghai AT songy eph100evaluationofcovid19vaccinesinprimarypreventionagainstinfectionsandreductioninseverityofillnessfollowingtheoutbreakofsarscov2omicronvariantinshanghai AT lij eph100evaluationofcovid19vaccinesinprimarypreventionagainstinfectionsandreductioninseverityofillnessfollowingtheoutbreakofsarscov2omicronvariantinshanghai AT lux eph100evaluationofcovid19vaccinesinprimarypreventionagainstinfectionsandreductioninseverityofillnessfollowingtheoutbreakofsarscov2omicronvariantinshanghai AT yangw eph100evaluationofcovid19vaccinesinprimarypreventionagainstinfectionsandreductioninseverityofillnessfollowingtheoutbreakofsarscov2omicronvariantinshanghai AT chenz eph100evaluationofcovid19vaccinesinprimarypreventionagainstinfectionsandreductioninseverityofillnessfollowingtheoutbreakofsarscov2omicronvariantinshanghai AT xuanj eph100evaluationofcovid19vaccinesinprimarypreventionagainstinfectionsandreductioninseverityofillnessfollowingtheoutbreakofsarscov2omicronvariantinshanghai AT baic eph100evaluationofcovid19vaccinesinprimarypreventionagainstinfectionsandreductioninseverityofillnessfollowingtheoutbreakofsarscov2omicronvariantinshanghai AT wangy eph100evaluationofcovid19vaccinesinprimarypreventionagainstinfectionsandreductioninseverityofillnessfollowingtheoutbreakofsarscov2omicronvariantinshanghai |